Nanotech, Single-Molecule Methods, Personalized Medicine Remain Top of Mind for VCs

Despite the recently soured economy, VCs have remained relatively optimistic about investment opportunities in the life science research tools and molecular diagnostics sectors, driven primarily by advances in nanotechnology, single-molecule genomics and proteomics techniques, and personalized medicine.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories